87297

Supelco

Tetrahexylammonium bromide

suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)

Linear Formula:
[CH3(CH2)5]4N(Br)
CAS Number:
Molecular Weight:
434.58
Beilstein/REAXYS Number:
3637302
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NB.21

Quality Level

description

cationic

assay

≥99.0% (AT)

quality

LiChropur

application(s)

ion pair chromatography: suitable

mp

99-100 °C (lit.)

λ

10 % in methanol

UV absorption

λ: 240 nm Amax: 0.06
λ: 250 nm Amax: 0.04
λ: 260 nm Amax: 0.03
λ: 500 nm Amax: 0.03

suitability

corresponds to standard for filter test

SMILES string

[Br-].CCCCCC[N+](CCCCCC)(CCCCCC)CCCCCC

InChI

1S/C24H52N.BrH/c1-5-9-13-17-21-25(22-18-14-10-6-2,23-19-15-11-7-3)24-20-16-12-8-4;/h5-24H2,1-4H3;1H/q+1;/p-1

InChI key

SYZCZDCAEVUSPM-UHFFFAOYSA-M

Looking for similar products? Visit Product Comparison Guide

General description

The utilization of ion-pairing reagents as mobile phase additives allows the elution of ionic and highly polar substances using reversed phase HPLC columns. The purity of mobile phase additives is a prime factor to their successful application. Sigma-Aldrich offers an outstanding collection of tailor-made reagents for anionic (quaternary ammonium and phosphonium salts) and cationic (alkanesulfonates) analyzes. All mobile phase additives are rigorously tested with special emphasis on the requirements of modern reversed phase HPLC:

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

LiChropur is a trademark of Merck KGaA, Darmstadt, Germany

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis

Certificate of Origin

Zeynep S Teksin et al.
Journal of controlled release : official journal of the Controlled Release Society, 116(1), 50-57 (2006-10-20)
Parallel Artificial Membrane Permeability Assay (PAMPA) is a method to screen drug candidates for membrane permeability. The objective was to characterize the transport of a model weak base, metoprolol, across a three lipid-component PAMPA system (denoted A-PAMPA, for anionic-PAMPA) and...
The effects of tetrahexylammonium chloride on calcium mobilization from cerebellar microsomes.
L G Sayers et al.
Biochemical Society transactions, 21(2), 105S-105S (1993-05-01)
A M Lisi et al.
Journal of chromatography, 581(1), 57-63 (1992-10-02)
A simple and efficient procedure has been developed for the derivatization of diuretic agents in human urine by direct extractive alkylation and their detection by gas chromatography-mass spectrometry. The procedure is an improvement over previous extractive alkylation methods because of...
N Surendran et al.
Journal of chromatography. B, Biomedical sciences and applications, 691(2), 305-312 (1997-04-11)
The objective of this research was to develop a rapid, sensitive and reliable method for the separation of phosphonodipeptide prodrugs and parent compounds to facilitate the evaluation of cell permeation using in vitro cell culture models. Separation was accomplished isocratically...
Xuemei Wang et al.
Journal of biomedical materials research. Part A, 80(4), 852-860 (2006-10-31)
Although much effort has been extended to the efficient cancer therapies, the drug resistance is still a major obstacle in cancer chemotherapeutic treatments. Almost 90% of the cancer therapy failure is caused by the relative problems. Recently, the application of...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.